Key points from article :
A new digital health company based in Tel Aviv, Longevity AI, has launched with an ambitious goal: to use artificial intelligence to help doctors extend patients’ healthy years of life. Emerging from stealth mode, Longevity AI announced a major partnership with KSM, the research arm of Maccabi Healthcare Services, Israel’s largest HMO. Together, they aim to use anonymized patient data to model the aging process and develop personalized strategies to slow it down—starting with cardiovascular disease, the world’s top cause of death.
Led by CEO Guy Leitersdorf, Longevity AI is designed for healthcare professionals rather than consumers. Its platform combines evidence-based medicine with behavioural science, helping doctors recommend tailored lifestyle interventions—such as diet, exercise, sleep, and stress management—that could delay or prevent the onset of chronic diseases. Unlike many existing risk models, which are based on outdated or narrow datasets, the platform integrates data from wearables, genetics, and patient records to give a fuller picture of health.
Leitersdorf, who previously worked in advertising AI, was inspired to enter the longevity field after losing his father to late-stage cancer. He hopes the same techniques used to understand consumer behaviour can be adapted to track health patterns and guide early, meaningful interventions. Through this partnership, Longevity AI and Maccabi aim to shift healthcare from reactive to proactive—empowering clinicians to act years before a disease develops.
